Literature DB >> 1960015

Effects of repeated administration of low doses of cisplatin on the rat nervous system.

G Cavaletti1, M G Petruccioli, G Tredici, P Marmiroli, I Barajon, D Fabbrica, A Di Francesco.   

Abstract

Cisplatin is a very effective antineoplastic drug. To date its major toxic dose-limiting effect is peripheral neuropathy. Whereas the clinical and neurophysiological features of cisplatin-induced neuropathy are fairly well known, its pathogenesis is still unclear. We treated a group of Wistar rats with low doses of cisplatin for 70 days in order to evaluate the light-microscopic and ultrastructural changes induced by chronic cisplatin administration in the spinal cord, spinal ganglia and peripheral nerves. Although the most striking pathological alterations were observed in the spinal ganglia neurons, initial axonal neuropathy was also demonstrated, whereas the spinal cord neurons were completely normal. Our findings further support the hypotheses that spinal ganglion neurons are the primary target of cisplatin peripheral neurotoxicity and that peripheral nerve damage is secondary to this neuronopathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1960015

Source DB:  PubMed          Journal:  Int J Tissue React        ISSN: 0250-0868


  13 in total

Review 1.  Animal models of peripheral neuropathies.

Authors:  Ahmet Höke
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

2.  Depletion of Mitofusin-2 Causes Mitochondrial Damage in Cisplatin-Induced Neuropathy.

Authors:  Ilja Bobylev; Abhijeet R Joshi; Mohammed Barham; Wolfram F Neiss; Helmar C Lehmann
Journal:  Mol Neurobiol       Date:  2017-01-21       Impact factor: 5.590

3.  Dorsal Root Ganglion Morphometric Changes Under Oxaliplatin Treatment : Longitudinal Assessment by Computed Tomography.

Authors:  Leonidas Apostolidis; Lars Kowalscheck; Tim Frederik Weber; Tim Godel; Martin Bendszus; Hans-Ulrich Kauczor; Dirk Jäger; Heinz-Peter Schlemmer; Philipp Bäumer
Journal:  Clin Neuroradiol       Date:  2021-09-09       Impact factor: 3.156

4.  Evaluation by somatosensory evoked potentials of the neurotoxicity of cisplatin alone or in combination with glutathione.

Authors:  G Bogliun; L Marzorati; G Cavaletti; L Frattola
Journal:  Ital J Neurol Sci       Date:  1992-11

5.  Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat.

Authors:  Valentina A Carozzi; Alessia Chiorazzi; Annalisa Canta; Rena G Lapidus; Barbara S Slusher; Krystyna M Wozniak; Guido Cavaletti
Journal:  Neurotox Res       Date:  2009-09-15       Impact factor: 3.911

6.  Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats.

Authors:  G Cavaletti; G Tredici; P Marmiroli; M G Petruccioli; I Barajon; D Fabbrica
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

7.  Impairment of retrograde neuronal transport in oxaliplatin-induced neuropathy demonstrated by molecular imaging.

Authors:  Dawid Schellingerhout; Lucia G LeRoux; Brian P Hobbs; Sebastian Bredow
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

8.  Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice.

Authors:  Cynthia L Renn; Valentina A Carozzi; Peter Rhee; Danisha Gallop; Susan G Dorsey; Guido Cavaletti
Journal:  Mol Pain       Date:  2011-04-26       Impact factor: 3.395

9.  Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli.

Authors:  Lauren E Ta; Philip A Low; Anthony J Windebank
Journal:  Mol Pain       Date:  2009-02-26       Impact factor: 3.395

10.  Long-term neurotoxicity of chemotherapy in adolescents and young adults treated for bone and soft tissue sarcomas.

Authors:  H M Earl; S Connolly; C Latoufis; K Eagle; C M Ash; C Fowler; R L Souhami
Journal:  Sarcoma       Date:  1998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.